A major new study has found that transcranial magnetic stimulation (TMS), which applies magnetic energy to the brain, can be ...

NEW YORK ― Transcranial magnetic stimulation (TMS) is a cost-effective treatment option for patients with resistant major depressive disorder (MDD), according to a new economic analysis. "It's mainly ...

For millions of people living with major depressive disorder, finding an effective treatment can feel like a never-ending ...

Transcranial magnetic stimulation (TMS, or "rTMS" for "repetitive TMS") received an indication for treating major depressive disorder in 2008. Since then, research and clinical experience with TMS has ...

Late-life depression (LLD) is a frequent complication of the aging process, occurring in up to 5% of senior adults and in a higher proportion of subjects with coexistent medical illnesses. The average ...

BURLINGTON, Mass. and JERUSALEM, Oct. 16, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BWAY) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...

Repetitive transcranial magnetic stimulation (rTMS) and other targeted, noninvasive neuromodulation approaches offer promise for treating neuropsychiatric conditions. These techniques work by ...

Moment of Clarity has published a new educational resource titled “Acccelerated TMS Therapy for Depression“, providing an in-depth look at how transcranial magnetic stimulation (TMS) technology is ...

Flow’s headset is the first tDCS device approved by the FDA ...